Rybelsus 7 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9S51
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,194
Award facts
- Contract value 100% obligated
- $15,193.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Rybelsus 7 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $15,193.81, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies a completion date of December 30, 2025, with fulfillment occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. Rybelsus is an oral diabetes medication used in the treatment and management of type 2 diabetes mellitus.
This delivery order is issued as a child contract under AmerisourceBergen's $999.999 billion prime IDC with DLA Troop Support Medical (SPE2DX), which operates through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capacity to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. The company's federal contract portfolio reflects consistent engagement with the Defense Logistics Agency and other government healthcare systems, positioning it as a critical vendor for pharmaceutical supply chain support to the Department of Defense and related federal agencies.
Quick answers
Who was awarded contract SPE2DR26F9S51?
SPE2DR26F9S51 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9S51 worth?
The government has obligated $15,194 on SPE2DR26F9S51.
Is contract SPE2DR26F9S51 an order under another contract?
Yes. SPE2DR26F9S51 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9S51 competed?
The extent of competition for SPE2DR26F9S51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award